McConn DJ[au] - Search Results

Year	Number of Results
2004	3
2007	1
2008	1
2009	1
2010	1
2021	1
2024	0

1

Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design.

McConn DJ, Zhao Z. McConn DJ, et al. Curr Drug Metab. 2004 Apr;5(2):141-6. doi: 10.2174/1389200043489063. Curr Drug Metab. 2004. PMID: 15078191 Review.

2

Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia.

Reichard HA, Schiffer HH, Monenschein H, Atienza JM, Corbett G, Skaggs AW, Collia DR, Ray WJ, Serrats J, Bliesath J, Kaushal N, Lam BP, Amador-Arjona A, Rahbaek L, McConn DJ, Mulligan VJ, Brice N, Gaskin PLR, Cilia J, Hitchcock S. Reichard HA, et al. Among authors: mcconn dj. J Med Chem. 2021 Aug 12;64(15):11527-11542. doi: 10.1021/acs.jmedchem.1c00820. Epub 2021 Jul 14. J Med Chem. 2021. PMID: 34260228

3

Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis.

McConn DJ 2nd, Lin YS, Mathisen TL, Blough DK, Xu Y, Hashizume T, Taylor SL, Thummel KE, Shuhart MC. McConn DJ 2nd, et al. Clin Pharmacol Ther. 2009 Apr;85(4):387-93. doi: 10.1038/clpt.2008.292. Epub 2009 Feb 11. Clin Pharmacol Ther. 2009. PMID: 19212316 Free PMC article.

4

Evidence of significant contribution from CYP3A5 to hepatic drug metabolism.

Huang W, Lin YS, McConn DJ 2nd, Calamia JC, Totah RA, Isoherranen N, Glodowski M, Thummel KE. Huang W, et al. Among authors: mcconn dj 2nd. Drug Metab Dispos. 2004 Dec;32(12):1434-45. doi: 10.1124/dmd.104.001313. Epub 2004 Sep 21. Drug Metab Dispos. 2004. PMID: 15383492

5

An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.

Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, McConn DJ. Reese MJ, et al. Among authors: mcconn dj. Drug Metab Dispos. 2008 Jul;36(7):1198-201. doi: 10.1124/dmd.107.020198. Epub 2008 Apr 17. Drug Metab Dispos. 2008. PMID: 18420781

6

Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs.

McConn DJ 2nd, Lin YS, Allen K, Kunze KL, Thummel KE. McConn DJ 2nd, et al. Drug Metab Dispos. 2004 Oct;32(10):1083-91. doi: 10.1124/dmd.32.10.. Drug Metab Dispos. 2004. PMID: 15377640

7

Dose-related reduction in bupropion plasma concentrations by ritonavir.

Park J, Vousden M, Brittain C, McConn DJ, Iavarone L, Ascher J, Sutherland SM, Muir KT. Park J, et al. Among authors: mcconn dj. J Clin Pharmacol. 2010 Oct;50(10):1180-7. doi: 10.1177/0091270009359524. Epub 2010 May 19. J Clin Pharmacol. 2010. PMID: 20484617

8

Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists.

Gong Y, Zhao Z, McConn DJ, Beaudet B, Tallman M, Speake JD, Ignar DM, Krise JP. Gong Y, et al. Among authors: mcconn dj. Pharm Res. 2007 Jun;24(6):1138-44. doi: 10.1007/s11095-007-9239-y. Epub 2007 Mar 21. Pharm Res. 2007. PMID: 17373577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year